Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Investing

Gilead Sciences : GILD

All Gilead Sciences Articles

736 Articles

Chris Lange | Oct 30, 2016 at 10:05 AM EDT

8 Top Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Starbucks and some of the major companies reporting their quarterly…

Chris Lange | Oct 26, 2016 at 7:15 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Oct 20, 2016 at 12:25 PM EDT

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Americans generally would like to spend less money on health care. One way that this can be and will be…

Lee Jackson | Oct 20, 2016 at 9:55 AM EDT

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.

Paul Ausick | Oct 13, 2016 at 4:04 PM EDT

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in…

Paul Ausick | Oct 12, 2016 at 4:04 PM EDT

Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club

October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in…

Chris Lange | Oct 12, 2016 at 7:10 AM EDT

Short Sellers Have Mixed Views on Major Biotechs

If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a…

Paul Ausick | Oct 11, 2016 at 4:04 PM EDT

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in…

Paul Ausick | Oct 7, 2016 at 4:04 PM EDT

Gilead, Mylan Return to Friday’s 52-Week Low Club

October 7, 2016: Here are four stocks trading with relatively heavy volume among 49 equities making new 52-week lows in…

Paul Ausick | Oct 6, 2016 at 4:04 PM EDT

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in…

Lee Jackson | Oct 6, 2016 at 9:50 AM EDT

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among…

Chris Lange | Sep 27, 2016 at 7:50 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest moves were upward across…

Lee Jackson | Sep 14, 2016 at 12:15 PM EDT

4 Jefferies Stealth Stock Picks for a Very Volatile Market

We liked the list of Buy-rated stocks in a recent Jefferies research piece, as they are all good stealth plays.…

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

Jon C. Ogg | Sep 12, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media…

1 … 23 24 25 26 27 … 50

Gilead Sciences : GILD

All Gilead Sciences Articles

8 Top Earnings for the Week Ahead

Short Sellers Can’t Make Up Their Minds on Major Biotechs

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club

Short Sellers Have Mixed Views on Major Biotechs

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Gilead, Mylan Return to Friday’s 52-Week Low Club

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

4 Jefferies Stealth Stock Picks for a Very Volatile Market

Short Sellers Run for Cover From Major Biotechs

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

At 88, He Still Climbs Ladders at His Shoe Store. His Age Ended the Earnings Test, but Not the Social Security Tax.

Housing Starts Plunge 10% as Mortgage Rates Climb to 6.75%, Builders Brace for Demand Collapse

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Gilead Sciences : GILD

All Gilead Sciences Articles

8 Top Earnings for the Week Ahead

Short Sellers Can’t Make Up Their Minds on Major Biotechs

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Ericsson, Nokia Stumble into Thursday’s 52-Week Low Club

Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club

Short Sellers Have Mixed Views on Major Biotechs

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Gilead, Mylan Return to Friday’s 52-Week Low Club

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

4 Jefferies Stealth Stock Picks for a Very Volatile Market

Short Sellers Run for Cover From Major Biotechs

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

Live: Will Webull Crush Q2 Earnings Tonight After Rising 7.5% Today?

Cramer Warns Fintech Bulls: These Three Stocks Are Priced for Perfection

Which Big Bank Stock Has Dominated in 2026: Bank of America, Wells Fargo, or Bank of New York Mellon Corp.?

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Featured Reads

At 88, He Still Climbs Ladders at His Shoe Store. His Age Ended the Earnings Test, but Not the Social Security Tax.

Housing Starts Plunge 10% as Mortgage Rates Climb to 6.75%, Builders Brace for Demand Collapse